* Immunomedics Inc., of Morris Plains, N.J., was issued U.S. patentNo. 5,541,297, which has 16 claims covering new conjugates usefulfor cancer or infectious diseases. The conjugates involve drugs ortoxins bound to a targeting substance, such as an antibody.
* MicroCarb Inc., of Gaithersburg, Md., was issued U.S. patent No.5,512,282, titled "Monospecific Polyclonal Antibodies to Shiga-LikeToxins." It covers production and use of antibodies to detect Shiga-like toxins or verotoxin producing strains of Escherichia coli0157:H7 for use in the company's VeroTest diagnostic.
* Polydex Pharmaceuticals Ltd., of Scarborough, Ontario, was issuedU.S. patent No. 5,514,665, titled "A Method of Preventing orReducing the Risk of Infection by Bacterial Pathogens UtilizingSimple and Conjugated Dextrans." Test have shown the company'sform of dextran thins mucous in the lungs and could be useful inrespiratory illnesses.
* ProCyte Corp., of Kirkland, Wash., was issued U.S. patent No.5,538,945, which claims a method for stimulating hair growth withpeptide-copper compounds; and U.S. patent No. 5,550,183, whichprovides method-of-use claims for three specific tripeptide-coppercompounds. It covers the hair-growth candidate PC1358 (Tricominsolution), which is in Phase II hair-loss studies.
(c) 1997 American Health Consultants. All rights reserved.